SPY Inc. Reports Results for the Third Quarter 2013 SPY

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
SPY Inc. Reports Results for the Third Quarter 2013

SPY Inc. Reports Results for the Third Quarter 2013
10th Consecutive Quarter of Year Over Year Growth of SPY(R) Brand Products; SPY(R) Brand Products Achieved Year to Date Growth of 8% in 2013; Total Company Year to Date Net Sales Reported as $29.2 Million

CARLSBAD, CA--(Marketwired - Nov 5, 2013) - SPY Inc. (OTCBB: XSPY) today announced financial results for the three and nine months ended September 30, 2013.

SPY® brand products were $29.1 million during the nine months ended September 30, 2013, an increase of 8% or $2.0 million greater than in of the same period in 2012. Total Company net sales increased by 6% or $1.7 million, to $29.2 million during the nine months ended September 30, 2013, compared to $27.5 million in the same period in 2012. The difference between our SPY® brand sales and total Company sales in 2012 was due to our discontinued licensed brand products, which will have no sales in the future. Discontinued licensed brand sales were less than $50,000 during the nine months ended September 30, 2013, compared with sales of $0.4 million in the same period of 2012. 

Third quarter sales of SPY® brand products were $10.2 million in 2013, an increase of 3% or $0.3 million greater than in the third quarter of 2012. Total Company net sales increased by 3% or $0.3 million, to $10.2 million compared to $9.9 million in the third quarter of 2012. There were no licensed brand sales in the third quarter of 2013, compared with $0.1 million in the third quarter of 2012.

"We are very happy to have achieved our 10th consecutive quarter of year over year growth of SPY® brand products, with strong SPY® brand year to date sales growth of 8% in 2013 over of the same period in 2012, and year to date sales in 2013 were 19% higher than the same period in 2011," said Michael Marckx, President and CEO. "In addition to the expanding Happy Lens™ Collection, we are pleased with the year to date growth of our Rx and goggle product lines that grew by 110% and 13%, respectively, in 2013 compared to 2012. The growth of these product lines helps diversify our revenue portfolio while expanding our SPY® brand. We achieved our third consecutive quarter of operating profit and had positive cash flow from operations. We believe our solid year to date results position us well for the fourth quarter of 2013 and into 2014."

Income from operations improved by $5.3 million to $0.8 in the nine months ended September 30, 2013, compared to a loss from operations of $4.5 million during the same period in 2012. The $5.3 million improvement was partially due to the increase in sales combined with a 400 basis point improvement in gross profit as a percent of sales, which generated $1.9 million in additional gross profit contribution. Additionally, total operating expenses in the nine months ended September 30, 2013 were lower by $3.3 million, compared to the same period in 2012, primarily a result of the restructure actions taken in the third quarter of 2012. Cash flow generated by operating activities was $2.5 million in the nine months ended September 30, 2013, compared to negative $4.1 million in the same period in 2012, or an improvement of more than $6.6 million.

Income from operations improved by $1.7 million to $0.5 in the third quarter of 2013, compared to a loss from operations of approximately $1.2 million in the third quarter of 2012. The $1.7 million improvement was partially due to the increase in sales combined with a 500 basis point improvement in gross profit as a percent of sales, which generated $0.6 million in additional gross profit contribution. Additionally, total operating expenses in the third quarter of 2013 were lower by $1.1 million, compared to the third quarter of 2012, primarily a result of the restructure actions taken in the third quarter of 2012. Cash flow provided by operating activities was $1.4 million in the third quarter of 2013, compared to negative $0.3 million in the third quarter of 2012, or an improvement of more than $1.7 million.

The net loss improved by $4.4 million to $1.6 million in the nine months ended September 30, 2013, compared to a net loss of $6.0 million during the same period in 2012. The net loss improved by $1.5 million to $0.3 million in the third quarter of 2013, compared to a net loss of $1.8 million in the third quarter of 2012. The improved net loss in each period was due to the reduction in our loss from operations, partially offset by higher interest expense. Interest expense included in the net losses is primarily "paid in kind" by being added to the outstanding principal balance rather than being paid in cash.

The results of our operations for the nine months ended and quarter ended September 30, 2013 and 2012 are more fully discussed in our Form 10-Q, filed with the Securities and Exchange Commission on November 5, 2013.

SPY Inc.:

We have a HAPPY disrespect for the usual way of looking (at life). This mindset helps drive us to design, market and distribute premium products for people who "live" to be outdoors, doing intense action sports, motorsports, snow sports, cycling and multi-sports-the things that make them HAPPY. We actively support the lifestyle subcultures that surround these pursuits, and as a result our products serve the broader fashion, music and entertainment markets of the youth culture. Our reason for being is to create the unusual, and this is what helps us deliver distinctive products to people who are active, fun and a bit irreverent, like us. It's what makes us HAPPY, and our customers, too. Our principal products-sunglasses, goggles and prescription frames-are happily marketed with fun and creativity under the SPY® brand. More information about SPY may be obtained from: www.spyoptic.com, www.facebook.com/spyoptic, Twitter @spyoptic and Instagram @spyoptic.

Safe Harbor Statement:

This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to future events or future financial performance and are subject to inherent risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "feel," "estimate," "predict," "hope," the negative of such terms, expressions of optimism or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause actual results to differ from those contained in our forward-looking statements include, but are not limited to: (i) lack of continuity of our management team, (ii) our ability to generate sufficient incremental sales of our core SPY® brand and new SPY® brand products to recoup our significant investments in sales, marketing and product development, (iii) our ability to continue to manage and operate our business at lower expense levels or otherwise reduce our breakeven point on an operating basis or to continue to generate income from operations, (iv) our ability to improve or maintain the levels of working capital necessary to operate the business, (v) our ability to maintain the availability of our existing credit facilities, satisfy our obligations when they become due, and otherwise finance our strategic objectives, and (vi) the other risks identified from time to time in our annual report on Form 10-K, our quarterly reports on Form 10-Q, and other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

   
   
SPY INC. AND SUBSIDIARIES  
CONSOLIDATED BALANCE SHEETS  
(Thousands, except number of shares and per share amounts)  
   
    September 30,     December 31,  
    2013     2012  
    (Unaudited)        
Assets            
Current assets            
  Cash   $ 702     $ 818  
  Accounts receivable, net     6,057       5,611  
  Inventories, net     6,375       6,274  
  Prepaid expenses and other current assets     463       770  
  Income taxes receivable     -       16  
                   
    Total current assets     13,597       13,489  
Property and equipment, net     437       446  
Intangible assets, net of accumulated amortization of $771 and $727 at September 30, 2013 and December 31, 2012, respectively     83       127  
Other long-term assets     80       85  
                 
    Total assets   $ 14,197     $ 14,147  
                 
Liabilities and Stockholders' Deficit                
Current liabilities                
  Lines of credit   $ 2,147     $ 4,591  
  Current portion of capital leases     78       49  
  Current portion of notes payable     16       15  
  Accounts payable     2,367       1,459  
  Accrued expenses and other liabilities     3,239       2,604  
                   
    Total current liabilities     7,847       8,718  
Capital leases, less current portion     109       102  
Notes payable, less current portion     20       32  
Notes payable to stockholders     20,856       19,078  
                 
    Total liabilities     28,832       27,930  
Stockholders' deficit                
  Preferred stock: par value $0.0001; 5,000,000 authorized; none issued     -       -  
  Common stock: par value $0.0001; 100,000,000 shares authorized; 13,168,497 and 13,098,374 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively     1       1  
  Additional paid-in capital     45,132       44,403  
  Accumulated other comprehensive income     509       494  
  Accumulated deficit     (60,277 )     (58,681 )
                 
    Total stockholders' deficit     (14,635 )     (13,783 )
                     
    Total liabilities and stockholders' deficit   $ 14,197     $ 14,147  
                     
                     
   
   
SPY INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS  
(Thousands, except per share amounts)  
   
  Three Months Ended
September 30,     Nine Months Ended
September 30,  
  2013     2012     2013     2012  
  (Unaudited)     (Unaudited)  
Net sales $ 10,152     $ 9,886     $ 29,154     $ 27,497  
Cost of sales   5,225       5,583       14,350       14,644  
                               
  Gross profit   4,927       4,303       14,804       12,853  
Operating expenses:                              
  Sales and marketing   2,963       3,838       8,767       11,262  
  General and administrative   1,269       1,351       4,505       5,075  
  Shipping and warehousing   121       224       379       607  
  Research and development   120       112       343       364  
                               
  Total operating expenses   4,473       5,525       13,944       17,308  
                               
  Income (Loss) from operations   454       (1,222 )     810       (4,455 )
Other income (expense):                              
  Interest expense   (745 )     (637 )     (2,229 )     (1,676 )
  Foreign currency transaction gain (loss)   (12 )     42       (174 )     80  
  Other income (expense)   1       33       (4 )     29  
                               
    Total other expense   (756 )     (562 )     (2,407 )     (1,567 )
                               
  Loss before provision for income taxes   (302 )     (1,784 )     (1,597 )     (6,022 )
Income tax provision   --       --       --       --  
                               
Net loss $ (302 )   $ (1,784 )   $ (1,597 )   $ (6,022 )
                               
Net loss per share of Common Stock                              
  Basic $ (.02 )   $ (0.14 )   $ (.12 )   $ (0.46 )
                                 
  Diluted $ (.02 )   $ (0.14 )   $ (.12 )   $ (0.46 )
                               
Shares used in computing net loss per share of Common Stock                              
  Basic   13,165       13,066       13,143       13,037  
                                 
  Diluted   13,165       13,066       13,143       13,037  
                               
Other comprehensive income (loss)                              
  Foreign currency translation adjustment $ (225 )   $ (125 )   $ (132 )   $ 34  
  Unrealized gain (loss) on foreign currency exposure of net investment in foreign operations   246       141       148       (45 )
                               
    Total other comprehensive income (loss)   21       16       16       (11 )
                               
Comprehensive loss $ (281 )   $ (1,768 )   $ (1,581 )   $ (6,033 )
                               
                               
                               
CONTACTS:
Maddy Isbell
PR Manager
760-804-8420
Fax: 760-804-8442
investor.spyoptic.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading
GEEKOM A5 2027: Mini PC Built to Boost Your Game

Updated Category News Views 2

GEEKOM Raises the Bar with A5 2027 Build Every once in a blue moon, a piece of tech pricks up my ears and this time it's the GEEKOM A5 2027 Edition. Released on September 7, 2026, this contraption's not just joining the ranks—it's looking to redefine them. It's geared for the real-world junkie who’s raking through browser tabs, dropping into video meetings, and making...

Continue Reading
CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Updated Category News Views 2

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 2

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Jixingfeng Advances Smart Manufacturing for Socks Market

Updated Category News Views 3

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Continue Reading
Europe's Largest Carbon Capture Facility Launches

Updated Category News Views 2

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
Innventure Faces Class Action: SEC Whistleblowers Invited

Updated Category News Views 1

When Fiction Meets the Stock Market Here's a wild twist in the investment world: Innventure, Inc. (NASDAQ: INV) found itself in hot water, as its stock took a nosedive, plunging 55% on August 14, 2026. Imagine seeing your investments crumble just like that. What lit this fire? The decision to yank their DarkNX project from 2026 expectations and hit pause on their revenue...

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the P/E Ratio of IDEXX Laboratories for Investors

Updated Category News Views 154

Understanding the P/E Ratio of IDEXX Laboratories IDEXX Laboratories Inc. (NASDAQ: IDXX) is currently trading at $766.68, reflecting a modest rise of 1.93%. Over the last month, there has been an impressive increase of 20.86%, and a remarkable jump of 81.78% over the past year. Such performance instills a sense of optimism among long-term shareholders, but it also raises...

Continue Reading
Current Market Dynamics of CRISPR Therapeutics: Insights and Trends

Updated Category News Views 158

Understanding CRISPR Therapeutics' Market Position CRISPR Therapeutics is on the radar of investors, with recent reports indicating that its short interest as a percentage of float has decreased by 5.29%. As it stands, there are approximately 22.07 million shares sold short, representing 27.41% of all regular shares available for trading. This percentage suggests a...

Continue Reading
Arixa Capital Achieves Record Loan Originations with Team Growth

Updated Category News Views 127

Arixa Capital Achieves Impressive Loan Originations Record Arixa Capital, a prominent player in the private real estate lending arena, has reached an exciting milestone by surpassing $440 million in loan originations during Q3 2024. This accomplishment not only emphasizes Arixa's stronghold in the market but also highlights its commitment to offering flexible financing...

Continue Reading
February New-Vehicle Sales: A Mixed Bag for Auto Enthusiasts

Updated Category News Views 232

February Sales Show Flicker of Hope Amid Challenges This month, the automotive market reveals a glimmer of recovery, albeit a tepid one. February's new-vehicle sales pace is projected to land at about 15.6 million, a modest boost from January’s 14.9 million but still trailing last February’s 16.0 million. That's a mixed bag if I've ever seen one. Sales volume for the...

Continue Reading
GA Telesis Expands Offerings with Landing Gear Acquisition

Updated Category News Views 147

GA Telesis Acquires AAR's Landing Gear Overhaul Business GA Telesis, LLC, a renowned provider of integrated aviation services, has embarked on an exciting journey that will redefine its service offerings. The company has officially signed an agreement to acquire AAR CORP.'s Landing Gear Overhaul business along with its Wheels & Brakes business unit. This strategic move...

Continue Reading